<code id='A248D89F54'></code><style id='A248D89F54'></style>
      • <acronym id='A248D89F54'></acronym>
      <center id='A248D89F54'><center id='A248D89F54'><tfoot id='A248D89F54'></tfoot></center><abbr id='A248D89F54'><dir id='A248D89F54'><tfoot id='A248D89F54'></tfoot><noframes id='A248D89F54'>
      • <optgroup id='A248D89F54'><strike id='A248D89F54'><sup id='A248D89F54'></sup></strike><code id='A248D89F54'></code></optgroup>
        5. <b id='A248D89F54'><label id='A248D89F54'><select id='A248D89F54'><dt id='A248D89F54'><span id='A248D89F54'></span></dt></select></label></b><u id='A248D89F54'></u>
          <i id='A248D89F54'><strike id='A248D89F54'><tt id='A248D89F54'><pre id='A248D89F54'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / explore / hotspot      
           
     
           
      
          hotspot 
           
      
           
      
           
       2025-09-30 08:59:09 
   
      
           
      
           
                        
          hotspot  
          
                                   
                 
                                      author：focus   
                                        
                                      
                                      Page View：7
                                  
                                    
          
                                   
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. 																									Ruby Wallau for STAT
          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.
          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.
          advertisement
          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.
          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!					
          GET STARTED													Log In											
                      
                              
          
                                 Previous article：

                                
                                          Option Care buys Amedisys in $3.6 billion home care deal
                                
                            
          Next article：  
                                      
                                          New air purifier tech could be key to improving indoor air quality
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles